RizkDChapmanAB.Cystic and inherited kidney diseases. Am J Kidney Dis2003; 42: 1305–1317.
2.
SalléeMRafatCZaharJR, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol2009; 4: 1183–1189.
3.
RyanAMcCookBSholoshB, et al. Acute intramural hematoma of the aorta as a cause of positive FDG PET/CT. Clin Nucl Med2007; 32: 729–731.
4.
RepkoBMTulchinskyM.Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET/CT. Clin Nucl Med2008; 33: 651–653.
5.
KwonHWLeeHYHwangYH, et al. Diagnostic performance of 18F-FDG-labeled white blood cell PET/CT for cyst infection in patients with autosomal dominant polycystic kidney disease: a prospective study. Nucl Med Commun2016; 37: 493–498.
6.
LantingaMACasteleijnNFGeudensA, et al. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review. Nephrol Dial Transpl2017; 32: 144–150.
7.
GilbertDN.Urinary tract infections in patients with chronic renal insufficiency. Clin J Am Soc Nephrol2006; 1: 327–331.
8.
MutherRSBennettWM.Cyst fluid antibiotic concentrations in polycystic kidney disease: differences between proximal and distal cysts. Kidney Int1981; 20: 519–522.
9.
GibsonPWatsonML.Cyst infection in polycystic kidney disease: a clinical challenge. Nephrol Dial Transplant1998; 13: 2455–2457.
10.
GambaroGFabrisAPuliattaD, et al. Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res2006; 34: 102–107.
11.
MarienTMassAYShahO.Antimicrobial resistance patterns in cases of obstructive pyelonephritis secondary to stones. Urology2015; 85: 64–68.